Literature DB >> 15966014

Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.

Danilo Fliser1, Stefan Wittke, Harald Mischak.   

Abstract

The introduction of fast, sensitive, and robust techniques for proteomic analysis into clinical practice represents a major step toward a new diagnostic approach of body fluids. In addition, proteomics emerges as a key technology for the discovery of disease biomarkers in various body fluids. However, even in relatively protein-deprived body fluids such as urine, the complexity and wide dynamic range of protein expression pose a considerable challenge to both separation and identification technologies. In the present review we discuss from a clinical point-of-view recent advances of the use of proteomics in clinical diagnosis as well as therapy evaluation. We focus on capillary electrophoresis coupled to mass spectrometry (CE-MS) and discuss CE-MS from an application point of view evaluating its merits and vices with regard to biomarker discovery. This review further presents examples of clinical applications of CE-MS for detection and identification of biomarkers in urine.

Mesh:

Substances:

Year:  2005        PMID: 15966014     DOI: 10.1002/elps.200500187

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  9 in total

1.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

2.  CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.

Authors:  Joshua J Coon; Petra Zürbig; Mohammed Dakna; Anna F Dominiczak; Stéphane Decramer; Danilo Fliser; Moritz Frommberger; Igor Golovko; David M Good; Stefan Herget-Rosenthal; Joachim Jankowski; Bruce A Julian; Markus Kellmann; Walter Kolch; Ziad Massy; Jan Novak; Kasper Rossing; Joost P Schanstra; Eric Schiffer; Dan Theodorescu; Raymond Vanholder; Eva M Weissinger; Harald Mischak; Philippe Schmitt-Kopplin
Journal:  Proteomics Clin Appl       Date:  2008-07-10       Impact factor: 3.494

3.  Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles.

Authors:  Masahiro Sugimoto; David T Wong; Akiyoshi Hirayama; Tomoyoshi Soga; Masaru Tomita
Journal:  Metabolomics       Date:  2009-09-10       Impact factor: 4.290

Review 4.  Immunoaffinity capillary electrophoresis as a powerful strategy for the quantification of low-abundance biomarkers, drugs, and metabolites in biological matrices.

Authors:  Norberto A Guzman; Timothy Blanc; Terry M Phillips
Journal:  Electrophoresis       Date:  2008-08       Impact factor: 3.535

Review 5.  Reconsidering adsorption in hemodialysis: is it just an epiphenomenon? A narrative review.

Authors:  Nans Florens; Fitsum Guebre-Egziabher; L Juillard
Journal:  J Nephrol       Date:  2021-04-10       Impact factor: 3.902

Review 6.  [Capillary electrophoresis coupled to mass spectrometry for proteome analysis. An innovative diagnostic method for prostate and bladder cancer].

Authors:  S Wittke; E Schiffer; H W Bauer
Journal:  Urologe A       Date:  2007-07       Impact factor: 0.803

7.  [Analysis of differentially expressed proteome in urine 
from non-small cell lung cancer patients].

Authors:  Zhengang Chen; Jinbo Liu; Ling Lin; Hui Xie; Wencheng Zhang; Hongbo Zhang; Guangshun Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-03

Review 8.  Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry.

Authors:  Jose L Luque-Garcia; Thomas A Neubert
Journal:  J Chromatogr A       Date:  2006-12-12       Impact factor: 4.759

9.  A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.

Authors:  K Benkali; P Marquet; Jp Rérolle; Y Le Meur; Ln Gastinel
Journal:  BMC Genomics       Date:  2008-11-14       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.